96 related articles for article (PubMed ID: 6794657)
21. [The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin].
Adam Z; Scudla V; Krejcí M; Korístek Z
Vnitr Lek; 2008 Jan; 54(1):68-83. PubMed ID: 18390120
[TBL] [Abstract][Full Text] [Related]
22. [IgM paraprotein associated with lymphoproliferative disorders].
Romero Colás MS; Silva Domínguez A; Tres Sańchez A; Montero Plaza M; Gómez Casal F; Pérez de las Vacas J; Gutiérrez Martín M; Jiménez Larrinaga A; Abós Olivares E; Fuertes Palacio MA
Rev Clin Esp; 1982 Sep; 166(5):225-8. PubMed ID: 6815731
[No Abstract] [Full Text] [Related]
23. Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chains.
Matsushita T; Sadamoto R; Ohyabu N; Nakata H; Fumoto M; Fujitani N; Takegawa Y; Sakamoto T; Kurogochi M; Hinou H; Shimizu H; Ito T; Naruchi K; Togame H; Takemoto H; Kondo H; Nishimura S
Biochemistry; 2009 Nov; 48(46):11117-33. PubMed ID: 19852465
[TBL] [Abstract][Full Text] [Related]
24. [Mechanism of the interference of the clotting mechanism by IgM type kappa from a patient with macroglobulinemia].
Murakami S; Inai S; Imaoka S
Nihon Ketsueki Gakkai Zasshi; 1986 May; 49(3):703-10. PubMed ID: 3094314
[No Abstract] [Full Text] [Related]
25. [Effective treatment with rituximab in two patients with Waldenström macroglobulinemia].
Yoshimi A; Arai S; Iijima K; Iki S; Usuki K; Urabe A
Rinsho Ketsueki; 2005 Oct; 46(10):1109-13. PubMed ID: 16440772
[TBL] [Abstract][Full Text] [Related]
26. Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study.
Ghobrial IM; Fonseca R; Greipp PR; Blood E; Rue M; Vesole DH; Gertz MA;
Cancer; 2004 Dec; 101(11):2593-8. PubMed ID: 15493038
[TBL] [Abstract][Full Text] [Related]
27. Physical-chemical characteristics of J chains obtained from IgM.
Inman FP
Adv Exp Med Biol; 1974; 45(0):167-70. PubMed ID: 4213296
[No Abstract] [Full Text] [Related]
28. [Immunoglobulins in hematology. Peripheral neuropathy associated with monoclonal IgM].
Brouet JC
Ann Med Interne (Paris); 1993; 144(8):518-20. PubMed ID: 8179240
[TBL] [Abstract][Full Text] [Related]
29. Structural studies on an IgM-lambda pyroglobulin.
Caulin-Glaser T; Prelli F; Franklin EC
J Lab Clin Med; 1982 Jun; 99(6):845-51. PubMed ID: 6804584
[TBL] [Abstract][Full Text] [Related]
30. Localization and overall structure of a mannose-rich glycopeptide from a pathologic immunoglobulin.
Jouanneau J; Fournet B; Bourrillon R
Biochim Biophys Acta; 1981 Feb; 667(2):277-84. PubMed ID: 6783117
[TBL] [Abstract][Full Text] [Related]
31. [Binding of natural IgM autoantibodies DJ to T-lymphocytes and T-cell hybridomas and its possible role in apoptosis].
Zivancević-Simonović S; Inić-Kanada A; Kosec D; Dimitrijević L
Med Pregl; 2003; 56 Suppl 1():65-71. PubMed ID: 15510917
[TBL] [Abstract][Full Text] [Related]
32. Docking of combinatorial peptide libraries into a broadly cross-reactive human IgM.
Yuriev E; Ramsland PA; Edmundson AB
J Mol Recognit; 2001; 14(3):172-84. PubMed ID: 11391788
[TBL] [Abstract][Full Text] [Related]
33. [Waldenström macroglobulinemia associated with cutaneous lesions and type I cryoglobulinemia].
del Olmo J; España A; Idoate MA; Panizo C
Actas Dermosifiliogr; 2008 Mar; 99(2):138-44. PubMed ID: 18346436
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the structural heterogeneity in the carbohydrate portion of a mouse monoclonal immunoglobulin A antibody.
Lipniunas P; Grönberg G; Krotkiewski H; Angel AS; Nilsson B
Arch Biochem Biophys; 1993 Jan; 300(1):335-45. PubMed ID: 8424667
[TBL] [Abstract][Full Text] [Related]
35. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
[TBL] [Abstract][Full Text] [Related]
36. [Monoclonal immunoglobulins].
Brouet JC
Ann Med Interne (Paris); 1996; 147(8):567-9. PubMed ID: 9137683
[TBL] [Abstract][Full Text] [Related]
37. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
[TBL] [Abstract][Full Text] [Related]
38. Dealing with intractable protein cores: protein sequencing of the Mcg IgG and the Yvo IgM heavy chain variable domains.
Shaw DC; Shultz BB; Ramsland PA; Edmundson AB
J Mol Recognit; 2002; 15(5):341-8. PubMed ID: 12447912
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of blood platelet aggregation by serum IgM macroglobulin. Preliminary report.
Farbiszewski R; Worowski K
Haematologia (Budap); 1970; 4(1):75-7. PubMed ID: 5001250
[No Abstract] [Full Text] [Related]
40. [M monoclonal macroglobulinemia induced in BALB/C mice. Effect on blood cholesterol and its significance].
Clerc G; Dumon MF; Seiwert E; Fleurentin J; Clerc M
Ann Biol Clin (Paris); 1986; 44(4):384-8. PubMed ID: 3098142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
